Skip to main content

Advertisement

Table 1 Characteristics of patients and treatment delivered

From: Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patients

Characteristic
Age 46 [24-74]
menopausal Status
 postmenopausal 31%
 Premenopausal 69%
Breast
 right 53%
 Left 47%
Tumor size
 T1 11%
 T2 50%
 T3 26%
 T4 13%
Ganglion involvement
 Positive 71%
 Negative 29%
Hormone receptor status
 Positive 67%
 Negative 33%
Surgery
 radical 78%
 conservative 22%
Chemotherapy
 Anthracycline 40%
 Taxanes (sequential) 60%
Radiotherapy 93%
 Right breast 49%
 Left breast 44%